Enterprise Profile: Yisheng Biopharmaceutical Co., Ltd. was established in 2002. Is a cross-country, cross-regional and Industry-University-Research-based biopharmaceutical enterprise integrating research and development, production and sales of vaccines for human use. Relying on R&D and innovation, the company developed the first domestic rabies vaccine without aluminum adjuvant and the first rabies immunoglobulin for human use, and successfully developed SARS immunoglobulin, which won the national patent.
Legal Representative: Zhang Yi.
Established: 1994-05-26
Registered capital: 410551160000 yuan.
Industrial and commercial registration number: 21011300004343.
Enterprise type: limited liability company (natural person investment or holding)
Company Address: Daxin No.2 Village, Cailuo Town, Xinchengzi District